"10.1371_journal.pone.0019392","plos one","2011-05-03T00:00:00Z","Thomas Krusenstjerna-Hafstr√∏m; Michael Madsen; Mikkel H Vendelbo; Steen B Pedersen; Jens S Christiansen; Niels M√∏ller; Niels Jessen; Jens O L J√∏rgensen","Department of Internal Medicine and Endocrinology (MEA) and Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark","Conceived and designed the experiments: TK-H MM MHV NM JSC NJ JOLJ. Performed the experiments: TK-H MHV. Analyzed the data: TK-H MM MHV SBP NM NJ JOLJ. Contributed reagents/materials/analysis tools: SBP NJ JSC. Wrote the paper: TK-H MM MHV SBP JSC NM NJ JOLJ.","The authors have the following competing interests: JOLJ has received unrestricted research grant and lecture fee from Pfizer Inc. The study was funded by Novo Nordisk. There are no patents, products in development or marketed products to declare. This does not alter the authors‚Äô adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have declared that no competing interests exist.","2011","05","Thomas Krusenstjerna-Hafstr√∏m","TKH√",8,FALSE,7,2,7,8,FALSE,FALSE,TRUE,1,"1",TRUE
